Ascorbate: Clinical Trials

7 trials of Ascorbate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 7
Phase 23Completed 3

Follow Ascorbate: new trials by email Literature Review of Ascorbate trials Research Report on Ascorbate

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.
Antioxidant therapy, NaCl 0.9% - Acute Myocardial Infarction, Ischemia-reperfusion Injury
Phase 1CompletedUniversity of Chile182022-08-092024-01-12
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
Ascorbate - Soft Tissue Sarcoma
Phase 1 / Phase 2CompletedMohammed Milhem252019-06-272026-06-18
High Dose Ascorbic Acid for Plasma Cell Disorders
Ascorbate, Melphalan - Multiple Myeloma
Phase 1CompletedChristopher Strouse62019-03-052025-10-21
A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
Vitamin C - Myelodysplastic Syndromes
Phase 1 / Phase 2CompletedNYU Langone Health42018-05-012024-03-27
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
Ascorbate, Gemcitabine, Radiation therapy - Pancreatic Neoplasms
Phase 1CompletedJoseph J. Cullen162014-01-012025-10-24
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
Ascorbate, Temozolomide, Radiation therapy - Glioblastoma, GBM
Phase 1CompletedJoseph J. Cullen, MD, FACS132013-04-012024-12-20
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Ascorbic Acid + Sorafenib, Sorafenib - Metastatic Hepatocellular Carcinoma, Advanced Liver Cancer
Phase 1 / Phase 2CompletedThomas Jefferson University52012-09-012025-05-04

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Glioblastoma (1)  ·  Liver Neoplasms (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Myocardial Reperfusion Injury (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Reperfusion Injury (1)  ·  Sarcoma (1)

Sponsors

Christopher Strouse (1)  ·  Joseph J. Cullen (1)  ·  Joseph J. Cullen, MD, FACS (1)  ·  Mohammed Milhem (1)  ·  NYU Langone Health (1)  ·  Thomas Jefferson University (1)  ·  University of Chile (1)

Countries

United States (6)  ·  Chile (1)

Top investigators

Abraham IJ Gajardo, MD, PhD (1)  ·  Christopher Strouse, MD (1)  ·  Daniel A Monti, MD, MBA (1)  ·  John M. Buatti, MD (1)  ·  Joseph J Cullen, MD (1)  ·  Joseph J Cullen, MD, FACS (1)  ·  Mohammad M Abdul Hay, MD (1)  ·  Mohammed Milhem, MBBS (1)

Results publications

PMID 28366679, PMID 30254147, PMID 38973337

NIH funding

P30CA086862 (1), U01CA140206 (1)